Differences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance

Autores da FMUP
Participantes de fora da FMUP
- Torres, S
- Magalhaes, A
- Garrido, L
- Costa, S
Unidades de investigação
Abstract
PurposeWomen with BRCA1 and BRCA2 (BRCA1/2) pathogenic/likely pathogenic (P/LP) variants have a higher risk to develop breast and ovarian cancer. In structured high-risk clinics, risk-reducing measures are adopted. This study aimed at characterizing these women and identify factors that may have influenced their choice between risk reduction mastectomy (RRM) and intensive breast surveillance (IBS).MethodsThis study reviewed retrospectively 187 clinical records of affected and unaffected women with P/LP variants of the BRCA1/2 genes, from 2007 to 2022, of which 50 chose RRM, while 137 chose IBS. The research focused on personal and family history and tumor characteristics and their relation with the preventive option chosen.ResultsAmong women with personal history of breast cancer, a higher proportion opted for RRM compared to those asymptomatic (34.2% vs 21.3%, p = 0.049), with younger age determining the option for RRM (38.5 years vs 44.0 years, p < 0.001). Among women with personal history of ovarian cancer, a higher proportion opted for RRM compared to those without that history (62.5% vs 25.1%, p = 0.033), with younger age determining the option for RRM (42.6 years vs 62.7 years, p = 0.009). Women who had bilateral salpingo-oophorectomy were more likely to choose RRM than those who did not (37.3% vs 18.3%, p = 0.003). Family history was not associated with preventive option (33.3% vs 25.3, p = 0.346).ConclusionsThe decision for the preventive option is multifactorial. In our study, personal history of breast or ovarian cancer, younger age at diagnosis, and previous bilateral salpingo-oophorectomy were associated with the choice of RRM. Family history was not associated with the preventive option.
Dados da publicação
- ISSN/ISSNe:
- 0171-5216, 1432-1335
- Tipo:
- Article
- Páginas:
- 7529-7538
- Link para outro recurso:
- www.scopus.com
Journal of Cancer Research and Clinical Oncology Springer Verlag
Documentos
- Não há documentos
Filiações
Keywords
- BRCA; Breast cancer; Pathogenic; likely pathogenic variants; Risk-reducing options
Financiamento
Proyectos asociados
Initial experience with Targeted Axillary Dissection after Neoadjuvant Therapy in breast cancer patients
Investigador Principal: José Luís Rosas Fougo
Estudo Clínico Académico . 2022
Assessment of the quality of care provided to patients with breast cancer after conservative treatment using the BREAST-Q®
Investigador Principal: José Luís Rosas Fougo
Estudo Clínico Académico . 2022
Citar a publicação
Torres S,Peleteiro B,Magalhaes A,Garrido L,Costa S,Fougo JL. Differences among a Portuguese cohort of <i>BRCA</i> pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance. J. Cancer Res. Clin. Oncol. 2023. 149. (10):p. 7529-7538. IF:3,600. (2).